Pzena Investment Management LLC Purchases 2,351 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Pzena Investment Management LLC boosted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 65.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,945 shares of the biopharmaceutical company’s stock after purchasing an additional 2,351 shares during the […]
More Stories
Price T Rowe Associates Inc. MD Has $1.23 Million Holdings in Embecta Corp. (NASDAQ:EMBC)
Price T Rowe Associates Inc. MD raised its stake in Embecta Corp. (NASDAQ:EMBC – Free Report) by 6.8% during the...
Hsbc Holdings PLC Sells 4,843 Shares of Stewart Information Services Co. (NYSE:STC)
Hsbc Holdings PLC lowered its position in shares of Stewart Information Services Co. (NYSE:STC – Free Report) by 50.4% in...
Tower Research Capital LLC TRC Reduces Holdings in TFS Financial Co. (NASDAQ:TFSL)
Tower Research Capital LLC TRC lowered its stake in TFS Financial Co. (NASDAQ:TFSL – Free Report) by 20.4% during the...
Pet Valu (TSE:PET) Price Target Raised to C$36.00
Pet Valu (TSE:PET – Free Report) had its target price boosted by Raymond James from C$34.00 to C$36.00 in a...
CRISPR Therapeutics (NASDAQ:CRSP) Given New $47.00 Price Target at The Goldman Sachs Group
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target lowered by equities research analysts at The Goldman Sachs...
Pet Valu (TSE:PET) Price Target Raised to C$33.00
Pet Valu (TSE:PET – Free Report) had its price target hoisted by National Bankshares from C$30.00 to C$33.00 in a...